• 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 1
  • 2
  • 3
  • →
  • »
Date   Headline
Feb 16, 2021 CEL-SCI Corporation Reports First Quarter Fiscal 2021 Financial Results
Jan 8, 2021 CEL-SCI Corporation to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference
Jan 4, 2021 CEL-SCI Corporation Issues Letter to Shareholders
Dec 30, 2020 CEL-SCI Reports Fiscal 2020 Financial Results and Clinical & Corporate Developments
Dec 14, 2020 CEL-SCI Corporation to Present at the 13th Annual LD Micro Main Event Conference
Dec 11, 2020 CEL-SCI Announces the Closing of Its $14.65 Million Bought Deal
Dec 8, 2020 CEL-SCI Announces Bought Deal Offering
Dec 7, 2020 CEL-SCI Announces Update on Phase 3 Cancer Trial Results
Dec 1, 2020 CEL-SCI’s LEAPS Peptides Demonstrate Clear Survival Benefit as a Treatment for COVID-19 in Preclinical Studies
Sep 18, 2020 CEL-SCI Awarded European Patent for LEAPS Vaccine in Treatment of Rheumatoid Arthritis